Trachoma

31 registered clinical trials studyying Trachoma — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs) NCT07322302	University of North Carolina, Chapel Hill	N/A
Withdrawn	Trachoma Elimination Study by Focused Antibiotic (TESFA) NCT03523156	Emory University	Phase 4
Withdrawn	Azithromycin Reduction to Reach Elimination of Trachoma B NCT06289647	University of California, San Francisco	Phase 4
Completed	Enhancing the A in SAFE for Trachoma NCT05634759	Emory University	Phase 4
Active Not Recruiting	Kebele Elimination of Trachoma for Ocular Health NCT03335072	University of California, San Francisco	Phase 4
Completed	Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin NCT03570814	London School of Hygiene and Tropical Medicine	Phase 4
Completed	Azithromycin Reduction to Reach Elimination of Trachoma NCT04185402	University of California, San Francisco	Phase 4
Completed	Safety and Immunogenicity of a Chlamydia Vaccine CTH522 NCT03926728	Statens Serum Institut	Phase 1
Terminated	App-based Versus Slide-based Inter-grader Agreement (IGA) Test for Trachoma Graders NCT04002726	London School of Hygiene and Tropical Medicine	N/A
Terminated	Smartphone App for Taking Images of Conjunctivae NCT03997487	London School of Hygiene and Tropical Medicine	N/A
Completed	Testing Insect Repellents Against Musca Sorbens, the Vector of Trachoma NCT03813069	London School of Hygiene and Tropical Medicine	Phase 2
Completed	Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs ) NCT03676140	Lihir Medical Centre	Phase 3
Withdrawn	Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population NCT02655432	Université de Montréal	—
Completed	Sanitation, Water, and Instruction in Face-washing for Trachoma I/II NCT02754583	University of California, San Francisco	Phase 3
Withdrawn	Nepal Elimination of Trachoma Study NCT02176057	University of California, San Francisco	Phase 2 / Phase 3
Completed	Water Uptake for Health in Amhara Pilot NCT02373657	University of California, San Francisco	N/A
Withdrawn	Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis NCT01903057	Emory University	Phase 4
Completed	Fluorometholone as Ancillary Therapy for TT Surgery NCT01949454	University of Pennsylvania	N/A
Completed	A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE Trial NCT01767506	Johns Hopkins University	N/A
Completed	Tripartite International Research for the Elimination of Trachoma NCT01202331	University of California, San Francisco	Phase 4
Completed	Modified Instrumentation for Surgery to Correct Trichiasis NCT00886015	Johns Hopkins University	N/A
Completed	Partnership for Rapid Elimination of Trachoma NCT00792922	Johns Hopkins University	Phase 4
Completed	A Trial of Non-absorbable Versus Absorbable Sutures for Trichiasis Surgery NCT00522860	London School of Hygiene and Tropical Medicine	Phase 4
Completed	Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger NCT00618449	University of California, San Francisco	Phase 4
Completed	Trachoma Amelioration in Northern Amhara (TANA) NCT00322972	University of California, San Francisco	Phase 4
Completed	Impact of Water and Health Education Programs on Trachoma and Ocular C. Trachomatis in Niger NCT00348478	Johns Hopkins University	Phase 4
Withdrawn	Azithromycin in Control of Trachoma II NCT00286026	University of California, San Francisco	Phase 4
Completed	Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trac NCT00356720	Laboratoires Thea	Phase 3
Completed	Trachoma Elimination Follow-up NCT00221364	University of California, San Francisco	Phase 4
Completed	Study of Three Alternatives for Mass Treatment in Trachoma Villages of Tanzania NCT00347607	Johns Hopkins University	Phase 4
Completed	Effect of Intensive Fly Control on Trachoma and Ocular Chlamydia Infection in Tanzania NCT00347763	Johns Hopkins University	Phase 4